SLC2A11 Knockout HCT 116 Cell Line
Cat.No.:
EDC07725
Species:
Human
Cell Name:
HCT 116
Gene:
SLC2A11
Gene ID:
66035
Size:
1×10⁶ cells
SLC2A11 Knockout Cell Line (HCT116) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07725 |
|---|---|
| Product Name | SLC2A11 Knockout HCT116 Cell Line |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene | SLC2A11 |
| NCBI Gene ID | |
| Gene Synonyms | GLUT10|GLUT11 |
| Summary |
This gene belongs to a family of proteins that mediate the transport of sugars across the cell membrane. The encoded protein transports glucose and fructose. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
|
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5-1/4, 2days |
| Complete Culture Medium | mcCoy5A + 10% FBS |
| Freezing Medium | 90% FBS / Complete culture medium + 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC2A11 function, SLC2A11 Knockout HCT 116 Cell Line or SLC2A11 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC2A11 (GLUT11)'s role in cancer cell hexose metabolism, particularly relevant for fructose handling in colorectal cancer contexts. The Knockout line is appropriate for asking whether GLUT11 contributes to fructose or glucose uptake in colorectal cancer cells — GLUT11's fructose preference makes it relevant for cancer cell sugar metabolism studies. Overexpression is useful for studying isoform-specific functions or for testing cancer-associated GLUT11 effects.
For colorectal cancer fructose metabolism research, the EDITGENE Knockout in HCT 116 is particularly relevant — fructose has emerging roles in colorectal cancer progression, and GLUT11 may contribute to fructose acquisition in this context. This product complements the parallel SLC2A11 Knockout in HEK293 (also available); HCT 116 is preferred for cancer biology studies and intestinal-derived contexts. Rescue with wild-type or transport-deficient GLUT11 enables structure-function studies.
What are the application scenarios for this model?
Primary applications:
• Cancer hexose metabolism: glucose and fructose uptake in the colorectal cancer context to assess GLUT11's contribution.
• Fructose-driven proliferation: assessment of fructose as a carbon source for HCT 116 proliferation in the absence of GLUT11.
• GLUT family expression analysis: characterization of GLUT1, GLUT3, GLUT5 compensatory expression in GLUT11-null colorectal cancer cells.
• CRC fructose biology: emerging research connects dietary fructose to colorectal cancer progression — GLUT11 KO enables direct testing of this hypothesis.
EDITGENE recommends this HCT 116-based model for colorectal cancer fructose metabolism research; the parallel SLC2A11 Knockout in HEK293 is preferred for biochemical mechanism studies.
Is this SLC2A11 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. GLUT11 rescue in HCT 116 is well-suited for cancer biology research:
• Construct design: use a codon-modified SLC2A11 sequence with a small C-terminal tag (FLAG, HA). Both N- and C-terminal cytoplasmic tags are typically tolerated.
• Cancer phenotype rescue: assessment of proliferation, anchorage-independent growth, and fructose utilization restoration following GLUT11 rescue.
• Transport-deficient rescue: substrate-binding pocket mutations enable distinguishing transport activity from non-transport functions in cancer biology.
• Functional readout: rescue should restore fructose and glucose uptake activities and colorectal cancer-relevant metabolic phenotypes.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download